K923070

Substantially Equivalent

WAKO IGG-HA

Applicant: Wako Chemicals USA, Inc.
Product code: CFN
Advisory panel: Immunology
Date received: 1992-06-25
Decision date: 1992-08-20
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Richmond, VA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.